Developer docs
API playgroundTry for free, no card

Search company profiles

Bellevue Asset Management

Full company profile

uuid000b729

Namestring
Bellevue Asset Management
Legal namestring
Bellevue Asset Management AG
Websiteurl
bellevue.ch
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Bellevue Asset Management AG is a Swiss specialty asset manager and wholly owned subsidiary of publicly listed Bellevue Group AG (SIX Swiss Exchange), founded in 1993 and headquartered in Zurich with offices in London, Frankfurt, Singapore, and Dublin. The firm operates as an active, fundamental bottom-up equity manager concentrated in three pillars: healthcare investments (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes via BB Biotech AG, the Bellevue Healthcare UCITS ETF, and dedicated thematic funds), small & mid-cap entrepreneurial investments (Swiss and European listed small-caps plus private equity strategies), and multi-asset/bond strategies (Bellevue Global Macro and Bellevue Global Income). Assets under management stood at CHF 4.8 billion at H1 2025, down from a 2021 peak of CHF 14.4 billion.

Short descriptiontext

Bellevue Asset Management AG is a Swiss specialty asset manager offering actively managed healthcare, small & mid-cap, and multi-asset funds to institutional, qualified, and retail investors across Europe and Asia Pacific.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKusnacht, Switzerland
HQ citystring
Kusnacht
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare investment management, equity fund management, small mid-cap investing, multi-asset strategies, active ETF management
Industry1 code
1Healthcare & Life Sciences Growth Equity
CodeFSANACABPrimaryYes
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Healthcare-focused asset management
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Fund Management Fees
TypeSubscription Recurring
Description

Recurring management fees charged on assets under management across Bellevue Funds (Lux) SICAV, Swiss investment funds, and third-party mandates. Fee income is directly tied to the AuM base, which stood at CHF 4.8 billion in H1 2025.

bellevue.ch
2Performance Fees
TypeSubscription Recurring
Description

Success fees charged when investment funds meet or exceed defined performance targets relative to their benchmarks, as described in fund documentation (BVI method).

bellevue.ch
3ETF Operations
TypeSubscription Recurring
Description

Revenue from actively managed Bellevue Healthcare UCITS ETF listed on SIX Swiss Exchange and Deutsche Börse Xetra, providing healthcare exposure through a UCITS-compliant wrapper.

bellevue.ch
4Operating Activities for BB Biotech AG
TypeManaged Services
Description

Bellevue Asset Management is responsible for the operating activities, administration, and marketing of BB Biotech AG, a separately listed investment company focused on biotechnology.

bellevue.ch
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 18 records shown
1Bellevue Healthcare ETF
Description

Actively managed UCITS ETF focused on global healthcare stocks, listed on SIX Swiss Exchange and Deutsche Börse Xetra.

bellevue.ch
+17 more records
Core offering1 text field

Bellevue Asset Management AG is a Swiss specialty asset manager that operates investment funds and mandates concentrated on healthcare (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes), small and mid-cap entrepreneur companies, and multi-asset/bond strategies. The firm manages BB Biotech AG, runs Luxembourg UCITS SICAV and Swiss-domiciled funds, and launched its first actively managed ETF (Bellevue Healthcare UCITS ETF) in September 2025.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Healthcare sector re-rating potential identified based on 13% valuation discount to global stocks, with USD 180 billion in biopharma M&A capacity.
+3 more records
Product overview1 text field

Bellevue Asset Management operates as a specialty investment manager offering a diversified portfolio of investment products. The core offering centers on Healthcare Investments including biotech (BB Biotech AG, Bellevue Biotech CH), medtech (Bellevue Medtech & Services), and thematic healthcare funds (Bellevue AI Health, Bellevue Digital Health, Bellevue Obesity Solutions, Bellevue Healthcare ETF). The Healthcare Global category includes diversified and sustainable healthcare strategies, while Regional Healthcare covers Asia Pacific and Emerging Markets. Beyond healthcare, Bellevue provides Small & Mid Sized Entrepreneur Investments including listed Swiss and European small caps and private equity (Bellevue Entrepreneur Private), plus Multi Asset & Bonds strategies (Bellevue Global Macro, Bellevue Global Income). The product suite operates across multiple legal structures including Swiss funds, Luxembourg SICAV, and UCITS ETFs, distributed through institutional and retail channels in Switzerland, Germany, Austria, Spain, and Luxembourg.

Product and service18 records
1BB Biotech AG
CategoryHealthcare Investment
Description

Investment company listed on SIX Swiss Exchange and German Prime Standard, focused on investing in biotechnology companies globally. Bellevue Asset Management is responsible for its operating activities, administration, and marketing.

2Bellevue Biotech (CH)
CategoryHealthcare Investment
Description

Swiss-domiciled fund focusing on biotechnology company investments for professional and qualified investors.

3Bellevue Medtech & Services
CategoryHealthcare Investment
Description

Fund investing in medical technology and healthcare services companies, marking over 15 years of active management.

4Bellevue AI Health
CategoryThematic Healthcare Investment
Description

Thematic fund focusing on AI-driven healthcare innovation and technologies.

5Bellevue Digital Health
CategoryThematic Healthcare Investment
Description

Thematic fund targeting digital health monitoring and healthcare technology companies.

6Bellevue Obesity Solutions
CategoryThematic Healthcare Investment
Description

Thematic fund focusing on companies addressing obesity treatment and related healthcare solutions.

7Bellevue Diversified Healthcare
CategoryHealthcare Global Investment
Description

Diversified healthcare fund providing broad exposure to the global healthcare sector.

8Bellevue Healthcare UCITS ETF
CategoryActive ETF
Description

Actively managed UCITS ETF investing in top healthcare stocks, listed on SIX Swiss Exchange and Deutsche Börse Xetra. Benchmark: MSCI World Healthcare Index.

9Bellevue Healthcare Strategy
CategoryHealthcare Global Investment
Description

Core healthcare equity strategy providing global healthcare exposure through active management.

10Bellevue Sustainable Healthcare
CategoryHealthcare Global Investment
Description

Sustainable healthcare fund incorporating ESG criteria into healthcare investments.

11Bellevue Asia Pacific Healthcare
CategoryHealthcare Regional Investment
Description

Regional healthcare fund focusing on Asia Pacific healthcare companies.

12Bellevue Emerging Markets Healthcare
CategoryHealthcare Regional Investment
Description

Regional healthcare fund focusing on emerging markets healthcare opportunities.

13Bellevue Entrepreneur Europe Small
CategorySmall & Mid Cap Investment
Description

Fund investing in small and mid-sized European entrepreneurial companies.

14Bellevue Entrepreneur Swiss Small & Mid
CategorySmall & Mid Cap Investment
Description

Fund investing in Swiss small and mid-sized companies.

15Bellevue Entrepreneur Switzerland (CH)
CategorySmall & Mid Cap Investment
Description

Swiss-domiciled fund focusing on Swiss entrepreneurial companies.

16Bellevue Entrepreneur Private
CategoryPrivate Equity Investment
Description

Private equity fund focused on entrepreneurial companies, including private equity secondaries and direct private market investments for qualified investors.

17Bellevue Global Macro
CategoryMulti Asset Investment
Description

Multi-asset fund using global macro investment strategies.

18Bellevue Global Income
CategoryBonds Investment
Description

Bond fund focused on global income strategies.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-30
Description

Columbia Threadneedle has been proposed by Bellevue Healthcare as the new fund manager for the Bellevue Healthcare Trust, as part of streamlining UK activities and operational restructuring.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-18
Description

Waystone ETF ICAV is the open-ended Irish collective asset-management vehicle (umbrella fund) that hosts the Bellevue Healthcare UCITS ETF sub-fund. Authorised by the Central Bank of Ireland. The ETF is registered for public distribution in Switzerland and Germany.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official representative in Switzerland for Bellevue Funds (Lux) SICAV, located at Avenue Villamont 17, CH-1005 Lausanne. Responsible for fund distribution oversight in the Swiss market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Paying agent in Switzerland for Bellevue Funds (Lux) SICAV, located at Münsterhof 12, CH-8022 Zürich. Handles subscription and redemption processing for Swiss investors.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

CACEIS Investor Services Bank S.A. is responsible for fund administration, custodian services, and order processing for Luxembourg-based Bellevue investment funds. Also serves as custodian for Bellevue Entrepreneur Switzerland.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Fund management company for Bellevue Funds under Swiss law, located at Bahnhofstrasse 9, 8001 Zürich. Responsible for fund administration and compliance for Swiss-regulated Bellevue investment funds.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Fund management company for Bellevue Entrepreneur Switzerland fund under Swiss law, located at Dammstrasse 23, 6300 Zug. Co-manages Swiss-regulated small and mid-cap entrepreneurial investment products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Custodian bank for Bellevue Funds under Swiss law, providing secure custody services for fund assets. Located in Zurich.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Information and paying agent for Germany and Austria, located at 19-22 Lower Baggot Street, Dublin 2, Ireland. Facilitates fund distribution and investor services for German and Austrian markets.

10VSG Datenschutzpartner UG
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

EU data protection representative appointed by Bellevue Group AG to serve as point of contact for supervisory authorities and data subjects on all EU data protection matters, located at Am Kaiserkai 69, D-20457 Hamburg.

bellevue.ch
11Prico GmbH
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

External data protection officer appointed for Bellevue Asset Management (Deutschland) GmbH, contacted via [email protected] at Unterer Markt 1, 49477 Ibbenbüren, Germany.

bellevue.ch
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-listed specialist asset manager with a strong healthcare and biotechnology fund franchise (Polar Capital Global Healthcare, Polar Capital Biotechnology). Direct competitor in the specialist healthcare equity space with similar size and active fundamental approach.

TypeBroad incumbent
Description

Swiss private bank-affiliated asset manager with Pictet Health and Pictet Quest for Health strategies. Larger Swiss competitor with healthcare offerings but broader multi-asset, multi-region franchise compared to Bellevue's focused specialist positioning.

TypeBroad incumbent
Description

World's largest asset manager with iShares Healthcare Innovation ETF and active healthcare strategies. Dominant incumbent with scale advantages in ETF and institutional channels that Bellevue's new UCITS ETF directly competes against.

TypeDirect peer
Description

Swiss asset manager with GAM Star Healthcare and similar specialty fund offerings. Comparable size and Swiss domicile, undergoing strategic restructuring - useful comparable for specialty asset manager economics.

TypeDirect peer
Description

Swiss-based healthcare-focused investment firm specializing in private and public healthcare investments. Highly comparable specialist healthcare investment model with similar Swiss domicile and concentrated healthcare mandate.

TypeBroad incumbent
Description

Swiss-listed asset manager with healthcare and multi-asset capabilities. Larger incumbent Swiss peer with broader product range but overlapping mid-cap and thematic healthcare exposures.

TypeBroad incumbent
Description

Global asset manager with T. Rowe Price Health Sciences and Global Biotechnology Funds. Established broad incumbent with deep healthcare research capabilities, larger scale, and global distribution - competitive threat for institutional mandates.

TypeDirect peer
Description

Swiss asset management arm of Zürcher Kantonalbank, already a distribution partner of Bellevue. Comparable Swiss fund manager with similar regulatory standing and overlapping institutional client base in Swiss market.

TypeBroad incumbent
Description

Global asset manager with dedicated healthcare funds (Janus Henderson Global Healthcare). Larger incumbent offering healthcare exposure but as part of broader multi-asset, multi-region platform rather than specialist focus.

TypeDirect peer
Description

Dutch asset manager with healthcare-focused strategies (including RobecoSAM Sustainable Healthy Living). Direct competitor in healthcare-specialist equity space with comparable active fundamental approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bellevue Asset Management

Healthcare-focused asset managementbellevue.ch

Bellevue Asset Management AG is a Swiss specialty asset manager offering actively managed healthcare, small & mid-cap, and multi-asset funds to institutional, qualified, and retail investors across Europe and Asia Pacific.

What Bellevue Asset Management does

Bellevue Asset Management AG is a Swiss specialty asset manager and wholly owned subsidiary of publicly listed Bellevue Group AG (SIX Swiss Exchange), founded in 1993 and headquartered in Zurich with offices in London, Frankfurt, Singapore, and Dublin. The firm operates as an active, fundamental bottom-up equity manager concentrated in three pillars: healthcare investments (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes via BB Biotech AG, the Bellevue Healthcare UCITS ETF, and dedicated thematic funds), small & mid-cap entrepreneurial investments (Swiss and European listed small-caps plus private equity strategies), and multi-asset/bond strategies (Bellevue Global Macro and Bellevue Global Income). Assets under management stood at CHF 4.8 billion at H1 2025, down from a 2021 peak of CHF 14.4 billion.

Bellevue Asset Management firmographics

Firmographics
Name
Bellevue Asset Management
Legal name
Bellevue Asset Management AG
Website
https://bellevue.ch
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
11–50 employees
Short description
Bellevue Asset Management AG is a Swiss specialty asset manager offering actively managed healthcare, small & mid-cap, and multi-asset funds to institutional, qualified, and retail investors across Europe and Asia Pacific.
Ownership category
akta.pro rank

Bellevue Asset Management industry classification

Industry
Product category
Healthcare-focused asset management
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

  • Healthcare investment management
  • Equity fund management
  • Small mid-cap investing
  • Multi-asset strategies
  • Active ETF management

Where Bellevue Asset Management is headquartered

Location

Headquarters

HQ city
Kusnacht
HQ country
Switzerland
HQ region
Europe

Offices5 records

Markets served

Bellevue Asset Management business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Fund Management Fees: Recurring management fees charged on assets under management across Bellevue Funds (Lux) SICAV, Swiss investment funds, and third-party mandates. Fee income is directly tied to the AuM base, which stood at CHF 4.8 billion in H1 2025.
  2. Performance Fees: Success fees charged when investment funds meet or exceed defined performance targets relative to their benchmarks, as described in fund documentation (BVI method).
  3. ETF Operations: Revenue from actively managed Bellevue Healthcare UCITS ETF listed on SIX Swiss Exchange and Deutsche Börse Xetra, providing healthcare exposure through a UCITS-compliant wrapper.
  4. Operating Activities for BB Biotech AG: Bellevue Asset Management is responsible for the operating activities, administration, and marketing of BB Biotech AG, a separately listed investment company focused on biotechnology.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Bellevue Asset Management product offering

Product offering

Core offering

Bellevue Asset Management AG is a Swiss specialty asset manager that operates investment funds and mandates concentrated on healthcare (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes), small and mid-cap entrepreneur companies, and multi-asset/bond strategies. The firm manages BB Biotech AG, runs Luxembourg UCITS SICAV and Swiss-domiciled funds, and launched its first actively managed ETF (Bellevue Healthcare UCITS ETF) in September 2025.

Product overview

Bellevue Asset Management operates as a specialty investment manager offering a diversified portfolio of investment products. The core offering centers on Healthcare Investments including biotech (BB Biotech AG, Bellevue Biotech CH), medtech (Bellevue Medtech & Services), and thematic healthcare funds (Bellevue AI Health, Bellevue Digital Health, Bellevue Obesity Solutions, Bellevue Healthcare ETF). The Healthcare Global category includes diversified and sustainable healthcare strategies, while Regional Healthcare covers Asia Pacific and Emerging Markets. Beyond healthcare, Bellevue provides Small & Mid Sized Entrepreneur Investments including listed Swiss and European small caps and private equity (Bellevue Entrepreneur Private), plus Multi Asset & Bonds strategies (Bellevue Global Macro, Bellevue Global Income). The product suite operates across multiple legal structures including Swiss funds, Luxembourg SICAV, and UCITS ETFs, distributed through institutional and retail channels in Switzerland, Germany, Austria, Spain, and Luxembourg.

Differentiator

Problem solved

Functional benefit

Brands

  • Bellevue Healthcare ETF: Actively managed UCITS ETF focused on global healthcare stocks, listed on SIX Swiss Exchange and Deutsche Börse Xetra.
  • Bellevue Medtech & Services
  • Bellevue Digital Health
  • Bellevue AI Health
  • Bellevue Obesity Solutions
  • Bellevue Diversified Healthcare
  • Bellevue Sustainable Healthcare
  • Bellevue Healthcare Strategy
  • Bellevue Asia Pacific Healthcare
  • Bellevue Emerging Markets Healthcare
  • Bellevue Biotech (CH)
  • Bellevue Entrepreneur Europe Small
  • Bellevue Entrepreneur Swiss Small & Mid
  • Bellevue Entrepreneur Switzerland (CH)
  • Bellevue Entrepreneur Private
  • Bellevue Global Macro
  • Bellevue Global Income
  • BB Biotech AG

Products and services

  • BB Biotech AG Investment company listed on SIX Swiss Exchange and German Prime Standard, focused on investing in biotechnology companies globally. Bellevue Asset Management is responsible for its operating activities, administration, and marketing.
  • Bellevue Biotech (CH) Swiss-domiciled fund focusing on biotechnology company investments for professional and qualified investors.
  • Bellevue Medtech & Services Fund investing in medical technology and healthcare services companies, marking over 15 years of active management.
  • Bellevue AI Health Thematic fund focusing on AI-driven healthcare innovation and technologies.
  • Bellevue Digital Health Thematic fund targeting digital health monitoring and healthcare technology companies.
  • Bellevue Obesity Solutions Thematic fund focusing on companies addressing obesity treatment and related healthcare solutions.
  • Bellevue Diversified Healthcare Diversified healthcare fund providing broad exposure to the global healthcare sector.
  • Bellevue Healthcare UCITS ETF Actively managed UCITS ETF investing in top healthcare stocks, listed on SIX Swiss Exchange and Deutsche Börse Xetra. Benchmark: MSCI World Healthcare Index.
  • Bellevue Healthcare Strategy Core healthcare equity strategy providing global healthcare exposure through active management.
  • Bellevue Sustainable Healthcare Sustainable healthcare fund incorporating ESG criteria into healthcare investments.
  • Bellevue Asia Pacific Healthcare Regional healthcare fund focusing on Asia Pacific healthcare companies.
  • Bellevue Emerging Markets Healthcare Regional healthcare fund focusing on emerging markets healthcare opportunities.
  • Bellevue Entrepreneur Europe Small Fund investing in small and mid-sized European entrepreneurial companies.
  • Bellevue Entrepreneur Swiss Small & Mid Fund investing in Swiss small and mid-sized companies.
  • Bellevue Entrepreneur Switzerland (CH) Swiss-domiciled fund focusing on Swiss entrepreneurial companies.
  • Bellevue Entrepreneur Private Private equity fund focused on entrepreneurial companies, including private equity secondaries and direct private market investments for qualified investors.
  • Bellevue Global Macro Multi-asset fund using global macro investment strategies.
  • Bellevue Global Income Bond fund focused on global income strategies.

Quantifiable outcome

  • Healthcare sector re-rating potential identified based on 13% valuation discount to global stocks, with USD 180 billion in biopharma M&A capacity.
  • +3 more outcomes

Companies that use Bellevue Asset Management

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Bellevue Asset Management technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Bellevue Asset Management partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor and core.

  • Columbia ThreadneedleminorChannel Partner/ Reseller/ Distributor · 30 October 2025Columbia Threadneedle has been proposed by Bellevue Healthcare as the new fund manager for the Bellevue Healthcare Trust, as part of streamlining UK activities and operational restructuring.
  • Waystone ETF ICAVcoreChannel Partner/ Reseller/ Distributor · 18 September 2025Waystone ETF ICAV is the open-ended Irish collective asset-management vehicle (umbrella fund) that hosts the Bellevue Healthcare UCITS ETF sub-fund. Authorised by the Central Bank of Ireland. The ETF is registered for public distribution in Switzerland and Germany.
  • Waystone Fund Services (Switzerland) SAcoreChannel Partner/ Reseller/ DistributorOfficial representative in Switzerland for Bellevue Funds (Lux) SICAV, located at Avenue Villamont 17, CH-1005 Lausanne. Responsible for fund distribution oversight in the Swiss market.
  • DZ PRIVATBANK (Schweiz) AGcoreChannel Partner/ Reseller/ DistributorPaying agent in Switzerland for Bellevue Funds (Lux) SICAV, located at Münsterhof 12, CH-8022 Zürich. Handles subscription and redemption processing for Swiss investors.
  • CACEIScoreChannel Partner/ Reseller/ DistributorCACEIS Investor Services Bank S.A. is responsible for fund administration, custodian services, and order processing for Luxembourg-based Bellevue investment funds. Also serves as custodian for Bellevue Entrepreneur Switzerland.
  • Swisscanto Fondsleitung AGcoreChannel Partner/ Reseller/ DistributorFund management company for Bellevue Funds under Swiss law, located at Bahnhofstrasse 9, 8001 Zürich. Responsible for fund administration and compliance for Swiss-regulated Bellevue investment funds.
  • PMG Investment Solutions AGcoreChannel Partner/ Reseller/ DistributorFund management company for Bellevue Entrepreneur Switzerland fund under Swiss law, located at Dammstrasse 23, 6300 Zug. Co-manages Swiss-regulated small and mid-cap entrepreneurial investment products.
  • Zürcher KantonalbankcoreChannel Partner/ Reseller/ DistributorCustodian bank for Bellevue Funds under Swiss law, providing secure custody services for fund assets. Located in Zurich.
  • Zeidler Legal Process Outsourcing Ltd.minorChannel Partner/ Reseller/ DistributorInformation and paying agent for Germany and Austria, located at 19-22 Lower Baggot Street, Dublin 2, Ireland. Facilitates fund distribution and investor services for German and Austrian markets.
  • VSG Datenschutzpartner UGminorImplementation/ SI/ Consulting PartnerEU data protection representative appointed by Bellevue Group AG to serve as point of contact for supervisory authorities and data subjects on all EU data protection matters, located at Am Kaiserkai 69, D-20457 Hamburg.
  • Prico GmbHminorImplementation/ SI/ Consulting PartnerExternal data protection officer appointed for Bellevue Asset Management (Deutschland) GmbH, contacted via [email protected] at Unterer Markt 1, 49477 Ibbenbüren, Germany.

Scale indicators13 records

Recent moves8 records

Expansion highlights5 records

Bellevue Asset Management competitors and assessment

Company assessment

Direct peers

  • Polar Capital Holdings: UK-listed specialist asset manager with a strong healthcare and biotechnology fund franchise (Polar Capital Global Healthcare, Polar Capital Biotechnology). Direct competitor in the specialist healthcare equity space with similar size and active fundamental approach.
  • GAM Investments: Swiss asset manager with GAM Star Healthcare and similar specialty fund offerings. Comparable size and Swiss domicile, undergoing strategic restructuring - useful comparable for specialty asset manager economics.
  • HBM Partners: Swiss-based healthcare-focused investment firm specializing in private and public healthcare investments. Highly comparable specialist healthcare investment model with similar Swiss domicile and concentrated healthcare mandate.
  • Swisscanto Asset Management: Swiss asset management arm of Zürcher Kantonalbank, already a distribution partner of Bellevue. Comparable Swiss fund manager with similar regulatory standing and overlapping institutional client base in Swiss market.
  • Robeco: Dutch asset manager with healthcare-focused strategies (including RobecoSAM Sustainable Healthy Living). Direct competitor in healthcare-specialist equity space with comparable active fundamental approach.

Broad incumbents

  • Pictet Asset Management: Swiss private bank-affiliated asset manager with Pictet Health and Pictet Quest for Health strategies. Larger Swiss competitor with healthcare offerings but broader multi-asset, multi-region franchise compared to Bellevue's focused specialist positioning.
  • BlackRock: World's largest asset manager with iShares Healthcare Innovation ETF and active healthcare strategies. Dominant incumbent with scale advantages in ETF and institutional channels that Bellevue's new UCITS ETF directly competes against.
  • Vontobel Asset Management: Swiss-listed asset manager with healthcare and multi-asset capabilities. Larger incumbent Swiss peer with broader product range but overlapping mid-cap and thematic healthcare exposures.
  • T. Rowe Price: Global asset manager with T. Rowe Price Health Sciences and Global Biotechnology Funds. Established broad incumbent with deep healthcare research capabilities, larger scale, and global distribution - competitive threat for institutional mandates.
  • Janus Henderson Investors: Global asset manager with dedicated healthcare funds (Janus Henderson Global Healthcare). Larger incumbent offering healthcare exposure but as part of broader multi-asset, multi-region platform rather than specialist focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Bellevue Asset Management social profiles

Digital presence

Bellevue Asset Management compliance and trust

Trust signal

Compliance9 records

Bellevue Asset Management financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bellevue Asset Management leadership team

Management profile

Number of profiles

Profiles1 record

Bellevue Asset Management subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Bellevue Asset Management funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bellevue Asset Management M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bellevue Asset Management

What does Bellevue Asset Management do?

Bellevue Asset Management AG is a Swiss specialty asset manager that operates investment funds and mandates concentrated on healthcare (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes), small and mid-cap entrepreneur companies, and multi-asset/bond strategies. The firm manages BB Biotech AG, runs Luxembourg UCITS SICAV and Swiss-domiciled funds, and launched its first actively managed ETF (Bellevue Healthcare UCITS ETF) in September 2025.

Is Bellevue Asset Management a public or private company?

Bellevue Asset Management is a private company. It is classified as corporate owned and is currently operating.

When was Bellevue Asset Management founded?

Bellevue Asset Management was founded in 1993. It employs 11 to 50 people.

Where is Bellevue Asset Management based?

Bellevue Asset Management is headquartered in Kusnacht, Switzerland, in the Europe region.

How does Bellevue Asset Management make money?

Four revenue lines are on record. Fund Management Fees are the primary driver. The others are performance Fees, ETF Operations and operating Activities for BB Biotech AG.

Who are Bellevue Asset Management's main competitors?

Direct peers on record are Polar Capital Holdings, GAM Investments, HBM Partners, Swisscanto Asset Management and Robeco. Broad incumbents are Pictet Asset Management, BlackRock, Vontobel Asset Management, T. Rowe Price and Janus Henderson Investors.

Does Bellevue Asset Management have an API?

No public API is recorded for Bellevue Asset Management.

What industry is Bellevue Asset Management in?

Bellevue Asset Management's product category is Healthcare-focused asset management. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsBellevue Asset Management LLC Has $1.51 Million Stake in NVIDIA Corporation $NVDABellevue Asset Management LLC cut its NVIDIA stake by 43.9% in Q2, selling 5,902 shares and holding 7,547 shares worth $1.51 million. Other institutions like LightSquare and Defender Capital added positions, while insiders sold 1.74 million shares in the quarter.finews.chWeshalb Bellevue ein Comeback der Medtech-Aktien siehtBellevue Asset Management sees a Medtech sector comeback, attributing recent weakness to capital flows into AI stocks. The sector's annualized 10-year return fell from 13.2% to 6.2%, but Bellevue expects growth of 6-7% annually through 2030. It highlights renal denervation and continuous potassium sensors as high-growth opportunities.finews.chBellevue Asset Management verstärkt Vertrieb Schweiz und ÖsterreichBellevue Asset Management has hired Michael Jöhr as Senior Sales for Switzerland and Austria, effective July, to strengthen its distribution team in those markets. Jöhr brings over 25 years of experience in fund distribution and relationship management, most recently serving as Head of Sales DACH at Exane Asset Management. The appointment supports Bellevue's growth ambitions in its core markets as part of a broader expansion of its global distribution structure under Florin Boetschi, who takes over as Global Head of Distribution in early 2026.FinanzNachrichten.deBellevue Entrepreneur Europe Small Fonds: 15 Jahre erfolgreiches Investieren in EuropaThe Bellevue Entrepreneur Europe Small Fonds, managed by Bellevue Asset Management, is celebrating its 15th anniversary with a track record built across varying market conditions in Europe. The fund, available in institutional (I EUR) and retail (B EUR) share classes, was highlighted in a press release from the asset manager. This marks a routine milestone announcement for the fund rather than a significant new development.FinanzNachrichten.deBellevue Asset Management AG: 15 Jahre erfolgreiches Investieren in Europa - und der Blick nach vornBellevue Asset Management AG announced the 15th anniversary of its Bellevue Entrepreneur Europe Small Fund, which has delivered an annualized net return of approximately 11% since inception, effectively quintupling the originally invested capital while outperforming its benchmark and ranking in the first quartile of competitors. The portfolio management team attributed this performance to a disciplined investment philosophy focused on entrepreneurially-led European small- and mid-cap companies, noting that around 30% of portfolio companies currently hold net liquidity with a portfolio average leverage below 1x Net Debt/EBITDA. Looking ahead, the team identifies attractive prospects driven by structural trends including electrification, AI infrastructure, energy efficiency, industrial automation, and reshoring, while highlighting that European small caps continue to trade below their historical valuation averages.finews.chBellevue regelt Nachfolge im Healthcare-TeamBellevue Asset Management has announced an early succession plan for its healthcare investment strategies, with Catharina Claes set to take on additional portfolio management responsibilities starting in early 2027. Marcel Fritsch will continue as Lead Portfolio Manager for both the Bellevue Medtech & Services and Bellevue Digital Health strategies, while Stefan Blum will step down from operational duties at the end of 2026 but remain with the firm as an Advisor. The company stated that the investment process, philosophy, and client service will remain unchanged, with plans to further strengthen the Healthcare Funds & Mandates team.finews.comLongevity: Where Medical Progress Creates Economic ValueBellevue Asset Management published an article positioning longevity as an investment theme, identifying a 9.6-year gap between global life expectancy and healthy life expectancy as the economic value driver. The piece highlights three value creation mechanisms — digital health monitoring, minimally invasive procedures, and targeted treatments for age-related diseases — while promoting its Bellevue Healthcare ETF as the vehicle to capture these opportunities. The article represents promotional content for a financial product rather than reporting on a specific event or development.Eqs-newsLongevity as an investment theme: where medical progress creates economic valueBellevue Asset Management AG published a market commentary on May 7, 2026, positioning longevity as an investment theme, citing that global life expectancy rose by 6.5 years between 2000 and 2019 while healthy life expectancy increased by only 5.4 years, creating a gap of 9.6 years with associated chronic disease costs. The firm identifies three value creation mechanisms along the longevity theme: digital health monitoring, minimally invasive procedures, and targeted pharmacotherapy for age-related diseases, and promotes its Bellevue Healthcare ETF as an investment vehicle targeting these areas.finews.asiaFive Reasons for a Strong Healthcare Year in 2026Healthcare sector analysts are projecting a strong 2026 for the industry, citing improved policy clarity following US drug pricing agreements with Pfizer, Eli Lilly, and Novo Nordisk that have reduced uncertainty and drawn $8 billion in new ETF capital to the sector. The report identifies five key drivers: re-rating potential as healthcare stocks trade at a 13% discount to global equities, a $180 billion biopharma M&A war chest, medtech growth in areas like continuous glucose monitoring projected to reach $21 billion by 2029, and emerging market innovation particularly in China and India. The piece, published by Bellevue Asset Management, notes significant performance divergence within the sector, with top performers gaining 72% while laggards fell 38% in H1 2025.TradingView5 reasons for strong healthcare year in 2026Bellevue Asset Management AG published a market commentary identifying five key developments supporting a strong healthcare sector outlook for 2026, including policy clarity from US drug pricing agreements with major pharmaceutical companies. The outlook highlights continued sector re-rating potential, USD 180 bn in biopharma M&A capacity, rapid medtech growth in areas like continuous glucose monitoring (projected to reach USD 21 bn by 2029), and attractive sector valuations trading at a 13% discount to global stocks. Emerging markets, particularly China and India, are highlighted as transforming from manufacturing bases to originators of specialty drugs and global therapy platforms.